LORAMYC®
• LORAMYC® 50 mg, muco‐adhesive buccal tablets.
• For more information, please refer to the Summary of Product Characteristics and patient leaflet: http://base-donnees-publique.medicaments.gouv.fr/
LORAMYC®
• LORAMYC® 50 mg, muco‐adhesive buccal tablets.
• For more information, please refer to the Summary of Product Characteristics and patient leaflet: http://base-donnees-publique.medicaments.gouv.fr/
Vectans Pharma is a European-based pharmaceutical company with a primary focus to target unmet needs in patients with oral pathologies through the acquisition and worldwide commercial development of innovative targeted therapeutics.
Our current portfolio includes Sitavig® and Loramyc®, 2 products approved by FDA and several authorities in Europe, and 1 proprietary innovative galenic technology : Lauriad®.
+33(0)1.41.21.90.16
contact@vectans.com
Copyright © VECTANS PHARMA